Clinical trial
Pulse Dexamethasone in Focal Segmental Glomerulosclerosis
NCT00004990 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pulse Dexamethasone in Focal Segmental Glomerulosclerosis
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2000
- Completion date
- December 31, 2004
- Enrollment
- 20
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.